theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Cardiology

Behavioral Neurology & Neuropsychiatry   

Questions discussed in this category


How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
4 Answers available
22199


Papers discussed in this category


The journal of prevention of Alzheimer's disease, 2023
Lecanemab: Appropriate Use Recommendations.

Stroke, 2024 Dec 11
Vascular Neurology Considerations for Antiamyloid Immunotherapy: A Science Advisory From the American Heart Association.

Related Topics in Cardiology

  • Lung Cancer
  • Breast Cancer
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Pediatric Hematology/Oncology
  • Radiation Physics

Copyright © 2025 theMednet
All Rights Reserved.